People
Filter News
Found 62,403 articles
-
ObsEva Announces Update on Board of Directors - March 19, 2024
3/19/2024
ObsEva SA announced that, concurrent to the decision to wind-down the company’s operations, Catarina Edfjäll, Ph.D. has decided to step down from the Board effective today.
-
Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services
3/18/2024
Kindeva Drug Delivery, a global leader in drug-device combination products, welcomes Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical services global business unit.
-
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
3/18/2024
Checkpoint Therapeutics, Inc. today announced the appointment of Amit Sharma, M.D., FACP, FASN, FNKF, to its Board as an independent, non-executive director, effective immediately.
-
Maplight Therapeutics Expands Executive Leadership Team With Appointment of Vishwas Setia as Chief Financial Officer
3/18/2024
MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering from debilitating CNS disorders, announced the appointment of Vishwas Setia as Chief Financial Officer.
-
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
3/18/2024
Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced that Victor Chong, M.D., MBA was appointed Chief Medical Officer on March 14, 2024.
-
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
3/18/2024
Syndax Pharmaceuticals, a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced the appointment of Steven Closter as Chief Commercial Officer, effective immediately.
-
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
3/18/2024
Chromocell Therapeutics Corp. today announced that its interim CEO Frank Knuettel, has been appointed as the Company’s permanent CEO.
-
Circular Genomics Adds Dr. Michael Ackermann, PhD, MBA to its Scientific Advisory Board
3/18/2024
Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced the addition of Michael F. Ackermann, PhD, MBA to its Scientific Advisory Board (SAB).
-
Abcam appoints Markus Lusser as new President
3/18/2024
Abcam today announced the appointment of Markus Lusser as President.
-
Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
3/18/2024
Fulcrum Therapeutics, Inc.® announced the appointment of Patrick Horn, M.D., Ph.D., as chief medical officer, effective immediately.
-
GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer
3/18/2024
GRO Biosciences Inc., an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics, announced the expansion of its leadership with the hire of Tracey Lodie, PhD as Chief Development Officer.
-
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
3/18/2024
Orthofix Medical Inc., a leading global spine and orthopedics company, announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer.
-
Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer
3/18/2024
Everest Medicines announced that the company has strengthened its management team with the appointments of Ms. Sandra Zeng as Chief Medical Officer and Mr. Rico Liang as Chief Product Officer.
-
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
3/18/2024
Oragenics, Inc. announced it has appointed Dr. James “Jim” Kelly, Neurologist, as its Chief Medical Officer, to oversee its upcoming Phase II clinical trial.
-
Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer
3/18/2024
Ocugen, Inc. announced the appointment of Dr. Huma Qamar as Chief Medical Officer.
-
Parexel Announces CEO Succession PlanChief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024
3/18/2024
Parexel today announced that Jamie Macdonald will retire and transition his role as Chief Executive Officer (CEO) to the company’s Chief Operating and Growth Officer Peyton Howell effective May 15, 2024.
-
Delcath Systems Appoints Martha S. Rook as Chief Operating Officer
3/18/2024
Delcath Systems, Inc. is pleased to announce the appointment of Martha S. Rook as its new Chief Operating Officer.
-
QT Imaging Holdings names Dr. Raluca Dinu as Acting Chief Executive Officer and Anastas Budagov as Chief Financial Officer
3/18/2024
QT Imaging Holdings, Inc. a medical device company engaged in research, development, and commercialization of innovative body imaging systems, announced that the Board of Directors has appointed former GigCapital5, Inc. CEO Dr. Raluca Dinu as Active Chief Executive Officer and member of the Board of Directors, effective March 12, 2024.
-
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
3/18/2024
Arvinas, Inc. announced the appointment of Noah Berkowitz, M.D., Ph.D., to the role of Chief Medical Officer and a member of the Executive Committee reporting to President and Chief Executive Officer John Houston, Ph.D. Effective today, Dr. Berkowitz will lead the ongoing clinical development of Arvinas’ PROTAC® protein degrader programs in oncology and neuroscience.
-
Cellino Announces Ed Tekeian as Senior Vice President of Engineering
3/18/2024
Cellino Biotech, Inc. today announced the expansion of its executive leadership team with the addition of Ed Tekeian as Senior Vice President of Engineering.